Client News

Vivoryon Therapeutics AG enters myeloid immune checkpoint drug discovery, and collaborates with the University of Kiel to select cancer therapy candidates from its QPCTL inhibitor portfolio

NOXXON announces launch of capital increase right issue for an amount of up to Euro 3.9 M

MagForce AG successfully resolves and completes capital increase from authorized capital under exclusion of statutory subscription rights

CENTOGENE Four Year Study Reveals Importance of Lyso-Gb1 in Monitoring Gaucher Disease Patients

Verona Pharma Strengthens its Clinical Team Ahead of Phase 3 Development of Ensifentrine

Expedeon AG introduces Lightning-Link® Metal Labelling Kits to support single cell analysis

NOXXON announces leading international pharma to evaluate NOX-A12 in new indication

Motif Bio plc: Motif Bio Presents New Iclaprim Data at ASM Microbe 2019

MorphoSys Appoints Jean-Paul Kress, M.D., as New Chief Executive Officer

CENTOGENE Accelerates Rare Disease Diagnosis with new Artificial Intelligence Solution